UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 521

Sortiert nach

Equilibria of homogeneous functionals in the fair-competition regime

Advances in nonlinear analysis, 2017-08, Vol.159, p.85-128

2017

Volltextzugriff (PDF)

Directional persistence of chemotactic bacteria in a traveling concentration wave

Proceedings of the National Academy of Sciences - PNAS, 2011-09, Vol.108 (39), p.16235-16240

2011

Volltextzugriff (PDF)

The best of both worlds: Combining population genetic and quantitative genetic models

Theoretical population biology, 2022-12, Vol.148, p.49-75

2022

Volltextzugriff (PDF)

Front acceleration by dynamic selection in Fisher population waves

Physical review. E, Statistical, nonlinear, and soft matter physics, 2012-10, Vol.86 (4 Pt 1), p.041908-041908, Article 041908

2012

Volltextzugriff (PDF)

Adaptation of a quantitative trait to a changing environment: New analytical insights on the asexual and infinitesimal sexual models

Theoretical population biology, 2023-08, Vol.152, p.1-22

2023

Volltextzugriff (PDF)

Persistent low-level viraemia in antiretroviral treatment-experienced patients is not linked to viral resistance or inadequate drug concentrations

Journal of antimicrobial chemotherapy, 2020-10, Vol.75 (10), p.2981-2985

2020

Volltextzugriff (PDF)

Dolutegravir as monotherapy in HIV-1-infected individuals with suppressed HIV viraemia

Journal of antimicrobial chemotherapy, 2016-09, Vol.71 (9), p.2646-2650

2016

Volltextzugriff (PDF)

Dynamics of drug resistance-associated mutations in HIV-1 DNA reverse transcriptase sequence during effective ART

Journal of antimicrobial chemotherapy, 2018-08, Vol.73 (8), p.2141-2146

2018

Volltextzugriff (PDF)

A mathematical model for mechanotransduction at the early steps of suture formation

Proceedings of the Royal Society. B, Biological sciences, 2013-05, Vol.280 (1759), p.20122670-20122670

2013

Volltextzugriff (PDF)

Prevalence and clinical impact of minority resistant variants in patients failing an integrase inhibitor-based regimen by ultra-deep sequencing

Journal of antimicrobial chemotherapy, 2018-09, Vol.73 (9), p.2485-2492

2018

Volltextzugriff (PDF)

Usefulness of an HIV DNA resistance genotypic test in patients who are candidates for a switch to the rilpivirine/emtricitabine/tenofovir disoproxil fumarate combination

Journal of antimicrobial chemotherapy, 2016-08, Vol.71 (8), p.2248-2251

2016

Volltextzugriff (PDF)

Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study

The Lancet (British edition), 2001-09, Vol.358 (9283), p.718-723

2001

Volltextzugriff (PDF)

HIV-1 Dynamics and Coreceptor Usage in Maraviroc-Treated Patients with Ongoing Replication

Antimicrobial Agents and Chemotherapy, 2013-02, Vol.57 (2), p.930-935

2013

Volltextzugriff (PDF)

Disparities in HIV‐1 transmitted drug resistance detected by ultradeep sequencing between men who have sex with men and heterosexual populations

HIV medicine, 2017-10, Vol.18 (9), p.696-700

2017

Volltextzugriff (PDF)

Prevalence of pre-existing resistance-associated mutations to rilpivirine, emtricitabine and tenofovir in antiretroviral-naive patients infected with B and non-B subtype HIV-1 viruses

Journal of antimicrobial chemotherapy, 2013-06, Vol.68 (6), p.1237-1242

2013

Volltextzugriff (PDF)

Low immune response rate of HIV-infected patients to a single injection of hepatitis A vaccine

Infectious diseases now (Online), 2021-02, Vol.51 (1), p.94-96

2021

Volltextzugriff (PDF)

Long-term efficacy of darunavir/ritonavir monotherapy in patients with HIV-1 viral suppression: week 96 results from the MONOI ANRS 136 study

Journal of antimicrobial chemotherapy, 2012-03, Vol.67 (3), p.691-695

2012

Volltextzugriff (PDF)

Performance of genotypic algorithms for predicting tropism for HIV-1 CRF01_AE recombinant

Journal of clinical virology, 2018-02, Vol.99-100, p.57-60

2018

Volltextzugriff (PDF)

Factors associated with virological response to a switch regimen containing maraviroc for antiretroviral-experienced HIV-1-infected patients

Journal of antimicrobial chemotherapy, 2016-09, Vol.71 (9), p.2651-2653

2016

Volltextzugriff (PDF)

Rilpivirine, emtricitabine and tenofovir resistance in HIV-1-infected rilpivirine-naive patients failing antiretroviral therapy

Journal of antimicrobial chemotherapy, 2014-04, Vol.69 (4), p.1086-1089

2014

Volltextzugriff (PDF)

Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease

The Lancet (British edition), 1998-06, Vol.351 (9117), p.1682-1686

1998

Volltextzugriff (PDF)

Second-line antiretroviral therapy failure and characterization of HIV-1 drug resistance patterns in children in Mali

Archives de pédiatrie : organe officiel de la Société française de pédiatrie, 2019-07, Vol.26 (5), p.254-258

2019

Volltextzugriff (PDF)

Resistance profiles of emtricitabine and lamivudine in tenofovir-containing regimens

Journal of antimicrobial chemotherapy, 2012-06, Vol.67 (6), p.1475-1478

2012

Volltextzugriff (PDF)

Impact of Discrepancies between the Abbott RealTime and Cobas TaqMan Assays for Quantification of Human Immunodeficiency Virus Type 1 Group M Non-B Subtypes

Journal of Clinical Microbiology, 2009-05, Vol.47 (5), p.1543-1545

2009

Volltextzugriff (PDF)

1 – 25 von 521

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(480)
Mit Volltextzugriff
(455)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Equilibria of homogeneous functionals in the fair-competition regime

Directional persistence of chemotactic bacteria in a traveling concentration wave

The best of both worlds: Combining population genetic and quantitative genetic models

Front acceleration by dynamic selection in Fisher population waves

Adaptation of a quantitative trait to a changing environment: New analytical insights on the asexual and infinitesimal sexual models

Persistent low-level viraemia in antiretroviral treatment-experienced patients is not linked to viral resistance or inadequate drug concentrations

Dolutegravir as monotherapy in HIV-1-infected individuals with suppressed HIV viraemia

Dynamics of drug resistance-associated mutations in HIV-1 DNA reverse transcriptase sequence during effective ART

A mathematical model for mechanotransduction at the early steps of suture formation

Prevalence and clinical impact of minority resistant variants in patients failing an integrase inhibitor-based regimen by ultra-deep sequencing

Usefulness of an HIV DNA resistance genotypic test in patients who are candidates for a switch to the rilpivirine/emtricitabine/tenofovir disoproxil fumarate combination

Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study

HIV-1 Dynamics and Coreceptor Usage in Maraviroc-Treated Patients with Ongoing Replication

Disparities in HIV‐1 transmitted drug resistance detected by ultradeep sequencing between men who have sex with men and heterosexual populations

Prevalence of pre-existing resistance-associated mutations to rilpivirine, emtricitabine and tenofovir in antiretroviral-naive patients infected with B and non-B subtype HIV-1 viruses

Low immune response rate of HIV-infected patients to a single injection of hepatitis A vaccine

Long-term efficacy of darunavir/ritonavir monotherapy in patients with HIV-1 viral suppression: week 96 results from the MONOI ANRS 136 study

Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 2006/2007 in France

Performance of genotypic algorithms for predicting tropism for HIV-1 CRF01_AE recombinant

Factors associated with virological response to a switch regimen containing maraviroc for antiretroviral-experienced HIV-1-infected patients

Rilpivirine, emtricitabine and tenofovir resistance in HIV-1-infected rilpivirine-naive patients failing antiretroviral therapy

Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease

Second-line antiretroviral therapy failure and characterization of HIV-1 drug resistance patterns in children in Mali

Resistance profiles of emtricitabine and lamivudine in tenofovir-containing regimens

Impact of Discrepancies between the Abbott RealTime and Cobas TaqMan Assays for Quantification of Human Immunodeficiency Virus Type 1 Group M Non-B Subtypes

Suchergebnisse filtern